Showing results (471-480 of 491) with videos related to

Sort By:
Pageof 50
Cancer Letters|March 10, 2024
Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interactionPhilip Weidner, Daniel Saar, Michaela Söhn, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
The New England Journal of Medicine|September 10, 2008
Continuous glucose monitoring and intensive treatment of type 1 diabetes, William V Tamborlane, Roy W Beck, et al.
Diabetes Care|May 12, 2009
The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Roy W Beck, Irl B Hirsch, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
Pageof 50